CD44 and breast carcinoma: Honeth et al., for instance, reported that using standard immunohistochemical methods on breast surgical samples, they could identify a clear variation in the prevalence of CD44+/CD24− tumour cells between tumours of different breast cancer subtypes, although they found no correlation with prognosis [5].